Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Holtzman

Showing results (261-270 of 293) with videos related to

Pageof 30
Sort By:
Leukemia & Lymphoma|July 9, 2019
Characteristics and outcomes of therapy-related myeloid neoplasms after treatment for multiple myelomaVu H Duong, Noa G Holtzman, Rima Koka, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 20, 2013
Blocks, ovals, or people? Icon type affects risk perceptions and recall of pictographsBrian J Zikmund-Fisher, Holly O Witteman, Mark Dickson, et al.
Cancer Chemotherapy and Pharmacology|March 7, 2021
Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimensSarah M Kashanian, Noa G Holtzman, Ciera L Patzke, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2016
Function and regulation of TRPP2 ion channel revealed by a gain-of-function mutantMahmud Arif Pavel, Caixia Lv, Courtney Ng, et al.
British Journal of Haematology|December 6, 2019
Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemiaNoa G Holtzman, Firas El Chaer, Maria R Baer, et al.
Acta Haematologica|January 30, 2019
Relapsed Philadelphia Chromosome-Positive Pre-B-ALL after CD19-Directed CAR-T Cell Therapy Successfully Treated with Combination of Blinatumomab and PonatinibFiras El Chaer, Noa G Holtzman, Edward A Sausville, et al.
Iscience|November 29, 2023
Chronic graft-versus-host disease is characterized by high levels and distinctive tissue-of-origin patterns of cell-free DNAYifan Pang, Temesgen E Andargie, Moon Kyoo Jang, et al.
Bone Marrow Transplantation|July 20, 2023
Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host diseaseDavid Beshensky, Filip Pirsl, Noa G Holtzman, et al.
Bone Marrow Transplantation|June 29, 2026
False-positive HIV-1 RNA detection following obecabtagene autoleucelJose F Camargo, Anthony D Anderson, Jay Spiegel, et al.
Bone Marrow Transplantation|September 8, 2023
Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host diseaseAaron T Zhao, Filip Pirsl, Seth M Steinberg, et al.
Pageof 30

Showing results (261-270 of 293) with videos related to

Sort By:
Pageof 30
Leukemia & Lymphoma|July 9, 2019
Characteristics and outcomes of therapy-related myeloid neoplasms after treatment for multiple myelomaVu H Duong, Noa G Holtzman, Rima Koka, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 20, 2013
Blocks, ovals, or people? Icon type affects risk perceptions and recall of pictographsBrian J Zikmund-Fisher, Holly O Witteman, Mark Dickson, et al.
Cancer Chemotherapy and Pharmacology|March 7, 2021
Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimensSarah M Kashanian, Noa G Holtzman, Ciera L Patzke, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2016
Function and regulation of TRPP2 ion channel revealed by a gain-of-function mutantMahmud Arif Pavel, Caixia Lv, Courtney Ng, et al.
British Journal of Haematology|December 6, 2019
Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemiaNoa G Holtzman, Firas El Chaer, Maria R Baer, et al.
Acta Haematologica|January 30, 2019
Relapsed Philadelphia Chromosome-Positive Pre-B-ALL after CD19-Directed CAR-T Cell Therapy Successfully Treated with Combination of Blinatumomab and PonatinibFiras El Chaer, Noa G Holtzman, Edward A Sausville, et al.
Iscience|November 29, 2023
Chronic graft-versus-host disease is characterized by high levels and distinctive tissue-of-origin patterns of cell-free DNAYifan Pang, Temesgen E Andargie, Moon Kyoo Jang, et al.
Bone Marrow Transplantation|July 20, 2023
Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host diseaseDavid Beshensky, Filip Pirsl, Noa G Holtzman, et al.
Bone Marrow Transplantation|June 29, 2026
False-positive HIV-1 RNA detection following obecabtagene autoleucelJose F Camargo, Anthony D Anderson, Jay Spiegel, et al.
Bone Marrow Transplantation|September 8, 2023
Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host diseaseAaron T Zhao, Filip Pirsl, Seth M Steinberg, et al.
Pageof 30